Molecular and Biochemical Insights into Morus nigra Extract: Its Role in Antioxidant Defense and Vascular Protection

Abdullaev A, Gayibov U, Gayibova S, Abduazimova D, Omonturdiev S and Aripov T

Published on: 2025-10-31

Abstract

Oxidative stress is a key factor contributing to vascular dysfunction and metabolic disturbances. Morus nigra extract, rich in bioactive compounds, is recognized for its antioxidant potential, yet its precise effects on vascular tone and oxidative stress parameters remain underexplored. This study evaluates the impact of Morus nigra extract on oxidative stress markers, vascular function, and mitochondrial stability using an alloxan-induced model, highlighting its potential as a protective agent. The investigation included assessments of aortic contraction, creatine kinase activity, malondialdehyde (MDA) levels, antioxidant enzyme function, mitochondrial swelling, acute toxicity, and secondary metabolite profiling. The experiments were conducted on an oxidative stress model induced by alloxan. Morus nigra extract exhibited strong antioxidant properties, reducing MDA accumulation and enhancing the activity of key antioxidant enzymes. Additionally, the extract influenced vascular responses by modulating aortic contractility and protected mitochondrial integrity under oxidative stress conditions. Acute toxicity analysis confirmed its safety profile, while phytochemical screening identified secondary metabolites that may contribute to its bioactivity.The findings support the potential of Morus nigra extract in mitigating oxidative stress and preserving vascular function. Its antioxidant and vasoprotective effects warrant further investigation for potential therapeutic applications.

Keywords

Alloxan model; Oxidative stress; Vascular function; Antioxidant defense; Mitochondrial protection

Introduction

Oxidative stress is a key factor in the pathogenesis of vascular dysfunction and metabolic disorders. The excessive production of reactive oxygen species (ROS) disrupts redox homeostasis, leading to lipid peroxidation, protein oxidation, and mitochondrial dysfunction, all of which contribute to endothelial impairment and vascular pathologies [1,2]. Antioxidant defense mechanisms, including enzymatic (superoxide dismutase, catalase, glutathione peroxidase) and non-enzymatic systems, play a crucial role in neutralizing oxidative damage. However, under pathological conditions such as metabolic disorders, these defense mechanisms are often insufficient, necessitating external antioxidant interventions [3,4].

Morus nigra (black mulberry) is a medicinal plant known for its rich composition of flavonoids, polyphenols, alkaloids, and other bioactive compounds. Several studies have demonstrated its potent antioxidant, anti-inflammatory, and metabolic regulatory effects [5,6]. These properties make it a promising candidate for mitigating oxidative stress-induced vascular dysfunction. However, the precise molecular and biochemical effects of Morus nigra extract on vascular contraction, mitochondrial integrity, and oxidative stress markers remain underexplored [7,8].

The present study aims to assess the vascular protective and antioxidant potential of Morus nigra extract using an alloxan-induced oxidative stress model. We investigated its effects on aortic contractility, creatine kinase activity, malondialdehyde (MDA) levels, antioxidant enzyme function, mitochondrial swelling, and acute toxicity. Additionally, the secondary metabolite composition of the extract was analyzed to identify key bioactive components. By elucidating these mechanisms, we aim to provide insights into the therapeutic potential of Morus nigra in vascular health and oxidative stress management.

Materials and Methods

Plant extraction

The dry extract of Morus nigra was provided by Bioton LLC, a company based in Tashkent, Uzbekistan.

Animal experiments

All manipulations with the animals complied with the European Directive 2010/63/EU on protecting animals used for scientific purposes (FAO. Directive 2010/63/EU on the protection of animals used for scientific purposes. Off J Eur Union. (2010):33-79.). The protocol was approved by the Animal Ethical Committee based on the Institute of Bioorganic Chemistry, AS RUz (Protocol Number: 133/1a/h, dated August 4, 2014).

Phytochemical analysis

The ethanolic extract of Morus nigra leaves was diluted in distilled water and subsequently analyzed for the presence of flavonoids [Hossain et al., 2013], saponins (Gul et al., 2017], phenols [Apostica et al., 2018], terpenoids (steroids) [Das et al., 2014], and tannins [Yadav et al., 2017]. Quantitative results are expressed numerically, indicating the measured concentrations of phytochemical compounds [9-13].

Determination of acute toxicity of the extract

Acute toxicity was assessed using the [Litchfield J.T., Wilcoxon F. A] method on 72 male white mice (20±2.0 g), divided into groups of six. All animals underwent a 10-14 day quarantine before the study [14].

The extracts PS-1, PS-2, and PS-3 were administered orally at different doses:

  • PS-1: 2500, 3200, 4000, 5000 mg/kg
  • PS-2: 1600, 2500, 3200, 4000 mg/kg
  • PS-3: 4000, 5000, 6000, 8000 mg/kg

Animals were monitored hourly for 24 hours and then daily for two weeks to assess survival, behavior, respiration, coat condition, feces, urination, and body weight changes.At the end of the experiment, the median lethal dose (LD??) was calculated, and the toxicity class was determined.

Alloxan-Induced Oxidative Stress

To model oxidative stress in experimental animals, alloxan monohydrate (Sigma, 140 mg/kg body weight) was used [Omolaoye et al., 2021] [15]. Alloxan was administered intraperitoneally using a freshly prepared solution of alloxan monohydrate in physiological saline.

Determination of malondialdehyde (MDA) content in various rat organs

The level of thiobarbituric acid reactive substances (TBARS), an indicator of malondialdehyde (MDA) formation and lipid peroxidation, was assessed in tissues using the method described by [Heath and Packer] [16]. For this, 1 mL of tissue supernatant was mixed with 4 mL of a 20% trichloroacetic acid (TCA) solution containing 0.5% thiobarbituric acid (TBA). The mixture was incubated in a water bath at 95°C for 30 minutes, then cooled, and the resulting MDA-TBA complex was measured using a spectrophotometer (UV/VIS) at a wavelength of 532 nm.

Investigation of the effects of extracts on the contractile activity of isolated aortic rings in laboratory rats

The experiments were conducted on aortic preparations from outbred male white rats weighing 200-250 g. The experimental animals were euthanized using cervical dislocation, after which the thoracic cavity was opened, and the aorta was surgically isolated and placed in a specialized 5 mL chamber for perfusion with Krebs-Henseleit physiological solution (mM): NaCl 120.4; KCl 5; NaHCO3 15.5; NaH2PO4 1.2; MgCl2 1.2; CaCl2 2.5; C6H12O6 11.5; HEPES, pH 7.4. In separate experiments, modified calcium-free Krebs solutions were also used, where EGTA (1 mM) was added to the solution. The physiological solutions were saturated with carbogen (95% O?, 5% CO?) and maintained at +37 °C using an U-8 ultrathermostat [Plamen I.Z et al, 2018] [17]. After removing the connective tissue and adipose layer, the aorta was cut into segments in the form of rings measuring 3-4 mm in length. The aortic rings were fixed to a Radnoti isometric transducer (USA) using platinum wire hooks. The rings were equilibrated for 60 minutes to reach a stable baseline tension. Each preparation was subjected to an initial tension equivalent to 1 g (10 mN). The contractile force was transmitted from the mechanotransducer to a signal amplifier and recorded on a computer using an automated Go-Link digital converter.

Investigation of the Effects of Extracts on Creatine Kinase Enzyme Activity

The homogenized rat myocardial tissue was centrifuged at 1500 rpm for 10 minutes to remove cellular fragments and large organelles. Creatine kinase activity was determined in the obtained supernatant using the liquid color reagent Creatine Kinase NAC. For the analysis, 40 µL of the reagent was added to 2 mL of the supernatant, and the kinetics of the enzymatic reaction were measured over 5 minutes using a UV-5100 spectrophotometer at a wavelength of 340 nm [Sudakov N.P et al, 2013] [18].

The rate of change in optical density was recorded, and enzyme activity was calculated using the following formulas:

  • At 25°C: Δ Abs/min × 4127 = U/L CK
  • At 37°C: Δ Abs/min × 8095 = U/L CK

Determination of antiradical activity by the DPPH method

The antiradical activity of the extracts was determined using the standard method by measuring the kinetics of optical density of the ethanolic solution of the DPPH (1,1-diphenyl-2-picrylhydrazyl) free radical (Sigma-Aldrich, USA). The concentration of the free radical was 0.1 mM, with a DPPH/polyphenol ratio of 1:10. Changes in the optical density of the DPPH ethanolic solution were recorded in cuvettes with a 1 cm optical path length, using a total volume of 3 mL, on a UV-5100 spectrophotometer.

Determination of Catalase Activity (Using the Hadwan M.H. Method, 2016) under in vivo conditions

Catalase activity was measured using the method proposed by Hadwan M.H. (2016) [19], with slight modifications. In this method, dichromate dissolved in acetic acid is reduced to chromium (III) in the form of chromium acetate under thermal conditions in the presence of hydrogen peroxide (H?O?), forming an unstable intermediate compound—perchromic acid. The concentration of hydrogen peroxide is directly related to the amount of chromium acetate produced. The quantitative determination of chromium acetate is performed colorimetrically at a wavelength of 570 nm, reflecting the level of catalase activity.

Determination of superoxide dismutase (SOD) activity (using the Nebot C et al. Method, 1993) under in vivo conditions

Superoxide dismutase (SOD) activity was determined according to the method described by Nebot C et al. (1993) [20], with slight modifications. Enzyme activity was assessed based on the ability of the sample to inhibit the formation of blue formazan by scavenging superoxide radicals generated in the riboflavin-light-NBT system. The reaction mixture contained 50 mM phosphate buffer (pH 7.6), 0.1 mg/mL riboflavin, 12 mM EDTA, and 0.1 mg/3 mL NBT, which were added sequentially. The reaction was initiated by exposing the mixture to light in the presence of different concentrations of the sample extract for 120 seconds. After illumination, absorbance was measured at 560 nm, and the EC50 value was calculated. Methanol was used as a blank control, while ascorbic acid served as a positive control. All experiments were conducted at 24-26°C using a spectrophotometer.

Isolation of Mitochondria

Mitochondria were isolated from rat liver (150-200 g) using differential centrifugation [Schneider, 1948] [21]. The liver was excised post-decapitation and placed in an ice-cold solution (250 mM sucrose, 10 mM Tris, pH 7.4). After weighing and blotting, the tissue was homogenized in a Teflon homogenizer with 6 volumes of isolation buffer (250 mM sucrose, 0.5 mM EDTA, 10 mM Tris, pH 7.4). Nuclei and debris were removed by centrifugation at 1500 rpm for 7 min at 0-1°C. Mitochondria were pelleted at 6000 rpm for 15 min and washed in EDTA-free buffer. The final mitochondrial pellet was resuspended to a protein concentration of 50-70 mg/ml and kept on ice throughout the experiment. All steps were performed at 0-2°C.

Determination of Lipid Peroxidation Products

The induction of non-enzymatic Fe²?/ascorbate-dependent lipid peroxidation (LPO) was carried out by adding 10?? M FeSO? and 2 × 10?? M ascorbate to the incubation medium, which contained 125 mM KCl, 10 mM Tris-HCl (pH 7.5), and a mitochondrial suspension at a concentration of 8 mg of protein per 1 mL of incubation medium. The incubation was conducted at 37°C in a water thermostat with continuous stirring. LPO was induced by the addition of various concentrations of HPA, with a maximum concentration of 4 × 10?³ M. The protein concentration in the system was approximately 8 mg/mL. The reaction was terminated by adding 0.2 mL of 70% TCA. The samples were then centrifuged at 3000 rpm for 15 minutes.Following centrifugation, 2 mL of the supernatant was collected and mixed with 1 mL of 80% TBA. In the control tube, 2 mL of water and 1 mL of TBA were added. The mixture was heated in a boiling water bath for 15 minutes. After cooling, the optical density was measured at 540 nm. The amount of malondialdehyde (MDA) formed was calculated using the molar extinction coefficient (ε = 1.56 × 10? M?¹ cm?¹) according to the following formula:
nmol MDA/mg protein = D / (1.56 × 30).

Results

In our experiment, we assessed the phytochemical composition of Morus nigra extract by quantifying key secondary metabolites, including phenols, terpenoids, saponins, flavonoids, and tannins. The total phenolic content was 0.175 ± 0.01 mg GAE, while terpenoids were present in negligible amounts. The saponin content was 0.413 ± 0.06 µg/mL GE. Flavonoids were measured at 0.071 ± 0.01 mg QE, and tannins at 0.086 ± 0.003 µg/mL EGC (Table 1). These results indicate that Morus nigra extract contains a moderate level of saponins and low levels of other phytochemicals.

Table 1: Phytochemical composition of Morus nigra extract.

Extract

Phenols, mg GAE (1 mg/10 mL distilled water)

Terpenoids, mg CE (mg/2 mL ethanol)

Saponins, µg/mL GE (100 mg/mL)

Flavonoids, mg QE

Tannins, µg/mL EGC

Morus nigra 

0,175 ± 0,01

 

0,413 ± 0,06

0,071 ± 0,01

0,086 ± 0,003

Notes:
GAE - Gallic acid equivalents.
CE - Cholesterol equivalents.

GE - Glycyrrhizic acid equivalents.
QE - Quercetin equivalents.
EGC - Epigallocatechin equivalents.

To assess the safety profile of Morus nigra extract, we further evaluated its acute toxicity in experimental models. Acute toxicity testing provides critical insights into the potential adverse effects of the extract upon a single high-dose administration. This assessment helps determine the lethal dose (LD??) and identify any immediate physiological or behavioral changes associated with the extract. To evaluate the acute toxicity of Morus nigra extract, a single-dose toxicity study was conducted in male mice. The extract was administered at a dose of 5000 mg/kg, and no mortality was observed in any of the tested animals (0/5). Based on these findings, the LD?? value for Morus nigra was determined to be greater than 5000 mg/kg, classifying it as a VI toxicity class substance, indicating a low acute toxicity risk.

Since the safety of Morus nigra extract has been established, the next phase of our study focused on its potential antioxidant activity under conditions of alloxan-induced oxidative stress. This model is characterized by excessive free radical production and lipid peroxidation, leading to oxidative damage. A key marker of oxidative stress is the malondialdehyde (MDA) level, which reflects the intensity of lipid peroxidation. Therefore, we proceeded with the determination of MDA content in various rat organs following alloxan-induced oxidative stress (Table 2).

Table 2: Malondialdehyde (MDA) content (nmol/mg protein) in various rat organs after Morus nigra extract administration.

Group, dose (mg/kg)

Brain

Heart

Kidneys

Small Intestine

Pancreas

Testes

Liver

Lungs

Control

10.94±0.42

11.65±0.15

9.19±0.36

12.71±0.36

8.85±0.41

8.44±0.15

11.65±0.15

12.06±0.31

Model

18.22±0.21

17.43±1.02

18.45±0.69

19.65±0.36

17.33±0.88

17.23±0.71

17.84±1.08

18.18±0.42

Morus nigra (25)

16.30±0.83

16.23±0.46

16.13±0.56

15.14±0.52

16.27±0.68

16.10±0.41

16.13±0.58

17.06±0.25

Morus nigra (50)

15.11±0.56

15.45±0.62

15.69±0.57

14.70±0.41

15.79±0.47

15.07±0.47

14.76±0.47

15.14±0.61

Morus nigra (75)

14.1 ± 0.57

14.25±0.21

14.90±0.46

14.94±0.61

14.70±0.72

14.49±0.72

14.39±0.51

14.12±0.46

Note: In all cases, p<0.05, indicating statistically significant differences between the diabetic group and other groups.

The table presents the malondialdehyde (MDA) content in various rat organs under different conditions: control, oxidative stress model, and treatment with Morus nigra extract at three different doses (25, 50, and 75 mg/kg). Oxidative stress induction (Model group) led to a significant increase in MDA levels across all organs compared to the Control group, indicating elevated lipid peroxidation. Treatment with Morus nigra resulted in a dose-dependent reduction in MDA levels. At 25 mg/kg, MDA levels were reduced but remained higher than the Control group. At 50 mg/kg, a more pronounced decrease was observed across all organs. At 75 mg/kg, MDA levels approached control values, suggesting strong antioxidant activity. The most notable reductions were seen in the brain, heart, kidneys, and pancreas, highlighting the potential protective effect of Morus nigra extract against oxidative stress in these organs. This data suggests that Morus nigra extract mitigates oxidative stress-induced lipid peroxidation in a dose-dependent manner.

To further evaluate the biological activity of Morus nigra extract, we investigated its impact on vascular function. Given the crucial role of endothelial dysfunction in oxidative stress-related pathologies, we examined the extract's effects on the contractile activity of isolated aortic rings in laboratory rats. This approach allows us to assess the potential vasorelaxant properties of Morus nigra and its influence on vascular tone regulation (Figure 1).

Figure 1: Contractile activity of aortic preparations from rats with alloxan-induced diabetes, induced by KCl (50 mM). The y-axis represents the contractile force of the aortic smooth muscle preparation induced by KCl (50 mM), taken as 100%. Statistical significance between the control group and the model ***p < 0.001, model (OS) and Morus nigra (ns), n =3-4.

A significant reduction in contraction force is observed in the Model (OS) group, which shows a highly significant decrease compared to the control group. Administration of Morus nigra extract did not significantly restore contractile activity, as indicated by the non-significant (ns) difference compared to the model (OS) group. Error bars represent the standard error of the mean (SEM).

The results indicate that Morus nigra extract did not significantly restore the impaired contractile activity of aortic rings in alloxan-induced diabetic rats, as evidenced by the lack of statistically significant differences compared to the model group. Although Morus nigra extract shows a tendency to improve contractile activity of aortic rings. Given these findings, we further investigated the effects of the extract on creatine kinase (CK) activity, a key enzyme involved in cellular energy metabolism, to better understand its potential protective mechanisms under oxidative stress conditions (Figure 2).

Figure 2: Changes in creatine kinase (CK) activity in response to oxidative stress. Statistical significance compared to the control group and the model group (OS) ***(p <0.001), the model group and Morus nigra *(p <0.05), n=3-4.

The model group shows a significant increase in CK activity compared to the control, indicating oxidative stress-induced damage. Administration with Morus nigra reduces CK levels compared to the model group, but the reduction is statistically significant at *p < 0.05. Error bars represent standard error of the mean (SEM), and n=3-4 per group.

Given the observed effects of Morus nigra extract in mitigating oxidative stress-induced changes, particularly its impact on creatine kinase activity, we hypothesized that its protective mechanism might be attributed to its antiradical properties. To further investigate this, we assessed the extract’s ability to scavenge free radicals using the DPPH method (Figure 3).

Figure 3: Determination of Antiradical Activity by the DPPH Method

To evaluate the potential antioxidant capacity of the extract, the DPPH radical scavenging assay was performed. The results demonstrated a concentration-dependent decrease in optical density (D), indicating a higher level of free radical neutralization with increasing extract concentration. The IC?? value, which represents the concentration required to inhibit 50% of DPPH radicals, was determined to be 21.47 µg/mL.

Having established that the extract exhibits significant antiradical activity through the DPPH assay, the next step involves investigating its influence on the enzymatic antioxidant defense system.

To further elucidate the extract’s protective mechanism, we assessed the activity of these key antioxidant enzymes. By examining their response to oxidative stress conditions, we can determine whether the extract enhances endogenous antioxidant defense, potentially contributing to its overall therapeutic efficacy.

Figure 4: SOD activity. The Y-axis of the graph represents the activity of the superoxide dismutase enzyme (percentage of O?•− inhibition) in liver homogenates of rats with diabetes. **p<0.01 — statistically significant differences when comparing the model group with the control group, as well as the model group with Morus nigra (ns), n=3-4.

The experimental data showed that in the model group, superoxide dismutase (SOD) activity was significantly reduced compared to the control, indicating pronounced oxidative stress. In the group receiving Morus nigra extract, there were no statistically significant differences in SOD activity compared to the model group (ns). This suggests that Morus nigra did not have a significant effect on SOD activity. Therefore, we continued our investigation of antioxidant activity by focusing on the catalase enzyme.

The results show that catalase activity was significantly reduced in the model group compared to the control, confirming oxidative stress in diabetic conditions. Administration of Morus nigra extract led to a partial restoration of catalase activity, with a statistically significant increase compared to the model group. However, catalase activity in the Morus nigra administrated group remained lower than in the control group, indicating that while the extract had a positive effect (Figure 5).

Figure 5: Catalase activity. The Y-axis of the graph represents the activity of the superoxide dismutase enzyme (percentage of H?O? inhibition) in liver homogenates of rats with diabetes. ***p<0.001 — statistically significant differences when comparing the model group with the control group, as well as the model group with Morus nigra *p<0.05, n=3-4.

The results indicate that Morus nigra extract did not show a significant effect on superoxide dismutase (SOD) activity, suggesting that it did not contribute to the regulation of superoxide anion detoxification. However, the extract demonstrated a positive effect on catalase activity, partially restoring its levels in diabetic conditions. This suggests that while Morus nigra does not significantly influence the SOD system, it may contribute to oxidative stress defense through catalase-mediated hydrogen peroxide decomposition.

Now that we have examined the activity of antioxidant enzymes, it is important to assess the effect of Morus nigra a on mitochondrial swelling, as this parameter reflects mitochondrial permeability and indirectly indicates the level of oxidative stress. Changes in mitochondrial size can signal dysfunction, which plays a key role in the pathogenesis of oxidative stress and other metabolic disorders.

The results indicate that Morus nigra extract exhibits a concentration-dependent protective effect against Fe²?/ascorbate-induced mitochondrial swelling. The inhibition of mitochondrial swelling became statistically significant at 6.66 µg/mL and continued to increase with higher concentrations. The IC?? value, representing the concentration at which Morus nigra reduces mitochondrial swelling by 50%, was determined to be 26.8 µg/mL (Figure 6).

Figure 6: The effect of Morus nigra extract on mitochondrial lipid peroxidation associated with the ferroptosis mechanism at different extract concentrations. The Y-axis represents the percentage of absorption, reflecting the level of lipid peroxidation, while the X-axis shows the extract concentrations (µg/mL). Statistically significant differences between the control group and the groups treated with Morus nigra extract were confirmed at significance levels of ***p<0.001, **p<0.01, *p<0.05, n=5-6.

This suggests that Morus nigra extract effectively stabilizes mitochondrial membranes and mitigates oxidative stress-induced permeability transition, highlighting its potential as a bioactive antioxidant.

Discussion

Oxidative stress is a key factor in the development of diabetes mellitus, and alloxan is widely used to induce diabetes in experimental models. Specifically, alloxan selectively targets pancreatic β-cells, leading to their destruction and subsequent insulin deficiency, ultimately resulting in hyperglycemia [Qamar et al.] [22]. Moreover, previous studies have demonstrated that significant β-cell loss impairs insulin secretion, further confirming alloxan-induced diabetes as a reliable model for studying oxidative stress-related metabolic disorders [Dalle et al.] [23].

Building on this understanding, recent research has explored potential therapeutic interventions to counteract oxidative stress-induced damage. One such candidate is Morus nigra, a plant with well-documented antioxidant properties. However, despite its potential benefits, studies on the cytotoxicity of Morus nigra indicate that while the extract is generally well-tolerated, excessive doses may induce mitochondrial dysfunction, altering ATP production and disrupting cellular homeostasis [Valente, M.J. et al. (2016)] [24]. Furthermore, certain secondary metabolites, such as alkaloids and tannins, have been reported to interact with cellular redox balance, potentially contributing to adverse effects at high concentrations [Zhang, L. et al. (2021)] [25].

In addition to these concerns, while polyphenols present in Morus nigra are known for their cardioprotective and neuroprotective properties, their metabolism can lead to the formation of reactive intermediates that may exert mild cytotoxic effects, particularly in metabolically stressed tissues [de Souza, L.M. et al. (2020)] [26]. Consequently, these findings highlight the importance of careful dose optimization to maximize therapeutic benefits while minimizing potential toxicity.

Therefore, future research should focus on long-term safety assessments, as well as the precise molecular pathways through which its bioactive compounds exert both protective and potentially harmful effects.

To further understand the biochemical composition of Morus nigra, our analysis revealed that the extract contains moderate saponin levels (0.413 ± 0.06 µg/mL GE) and low amounts of phenols (0.175 ± 0.01 mg GAE), flavonoids (0.071 ± 0.01 mg QE), and tannins (0.086 ± 0.003 µg/mL EGC), with negligible terpenoid content. When comparing these findings to previous studies, we observed that while our saponin levels appear higher than some reported values in the literature [Imran et al., 2021], the flavonoid and phenolic content remains consistent with prior research, thereby reinforcing the antioxidant potential of Morus nigra [Katsube et al., 2006]. These variations may be attributed to differences in plant origin, extraction methods, or maturity [27,28].

Given the central role of oxidative stress in disease progression, it is crucial to evaluate its impact on lipid peroxidation, which is often assessed through malondialdehyde (MDA) levels. According to Noeman et al. (2011) [29], oxidative stress markers, including MDA, were significantly elevated in the liver, kidney, and heart of rats subjected to a high-fat diet, demonstrating the impact of obesity-induced oxidative stress on multiple organs. These findings underscore the importance of antioxidant interventions to counteract lipid peroxidation and protect organ function, our study expands this perspective by providing a broader evaluation across multiple tissues. The findings confirm increased lipid peroxidation under oxidative stress conditions, reinforcing the need for effective antioxidant interventions to mitigate cellular damage.

Furthermore, superoxide dismutase (SOD) plays a critical role in protecting cells from oxidative stress and regulating cellular homeostasis. According to research by Wang et al., SOD not only neutralizes superoxide radicals but also modulates key cellular processes. In our study, we observed a significant decrease in SOD activity in the model group, confirming oxidative stress-induced damage. However, despite the antioxidant properties of Morus nigra, its administration did not significantly restore SOD activity. This suggests that its protective effects may occur through alternative pathways rather than direct SOD upregulation.

Considering the importance of enzymatic antioxidant defense, we also assessed catalase activity, as this enzyme plays a crucial role in decomposing hydrogen peroxide—a major reactive oxygen species—thereby mitigating oxidative stress [Aladyeva & Zimatkin] [30]. In alignment with previous studies, our results show a substantial decrease in catalase activity in the model group. However, following Morus nigra administration, catalase activity was partially restored, indicating a protective effect, albeit not to control levels.

Beyond enzymatic defenses, oxidative stress is also known to induce endothelial dysfunction, increasing vascular permeability and inflammation, which can contribute to aortic damage [Ren et al.] [31]. To further assess oxidative stress-induced damage, we measured creatine kinase (CK) activity, a well-established marker of cellular injury. Our findings demonstrate a significant increase in CK activity in the model group, which is consistent with previous reports [Golubovic & Slezak] [32]. Notably, Morus nigra administration resulted in a moderate yet statistically significant reduction in CK levels, suggesting a protective effect on vascular tissues.

To strengthen our assessment of Morus nigra’s antioxidant potential, we evaluated its ability to scavenge free radicals and protect cellular structures from oxidative damage. Encouragingly, our findings confirm that Morus nigra exhibits significant antioxidant activity, reinforcing its potential therapeutic application in oxidative stress-related disorders.

Moreover, mitochondrial dysfunction is another critical consequence of oxidative stress, as it contributes to cellular energy deficits and apoptotic signaling. One of the key indicators of mitochondrial damage is mitochondrial swelling, which reflects increased membrane permeability and impaired oxidative phosphorylation. Under oxidative stress conditions, excessive reactive oxygen species (ROS) production disrupts mitochondrial integrity, leading to membrane potential loss and cell death cascades [Li & Miao] [33]. Our study demonstrates that Morus nigra exerts a concentration-dependent protective effect against Fe²?/ascorbate-induced mitochondrial swelling, with an IC?? value of 26.8 µg/mL. This indicates a moderate yet promising capacity for mitochondrial stabilization.

Finally, as research into oxidative stress-related pathologies continues to evolve, recent studies have sought to further elucidate the molecular mechanisms underlying mitochondrial swelling, aiming to develop therapeutic strategies that mitigate mitochondrial dysfunction and subsequent cell death. In this context, our findings contribute to this growing body of research, highlighting the potential of Morus nigra as a candidate for further exploration in oxidative stress-related conditions, including diabetes and cardiovascular diseases.

Funding

This work received no funding from any source

Acknowledgment

The authors express their gratitude to the Laboratory of Plant Cytoprotectors, Institute of Bioorganic Chemistry named after Academician A.S. Sadykov, Academy of Sciences of the Republic of Uzbekistan, Tashkent, Uzbekistan, for providing the necessary equipment and reagents for this study.

References

  1. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine J. Oxford University Press. 2015.
  2. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease J. Physiol Rev. 2007; 87: 315-424.
  3. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39: 44-84.
  4. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012; 5: 9-19.
  5. Ercisli S, Orhan E. Chemical composition of white (Morus alba) and black (Morus nigra) mulberry fruits. J Sci Food Agric. 2007; 87: 2612-2616.
  6. Imran M, Salehi B, Sharifi-Rad J, Gondal TA, Saeed F, Imran A, et al. Black mulberry (Morus nigra): A review on its food applications, phytochemistry, and pharmacological properties. Clin Nutr. 2021; 40: 3083-3101.
  7. Abdullaev AA, Inamjanov DR, Abduazimova DS, Omonturdiyev SZ, Gayibov UG, Gayibova SN, et al. Silybum mariánum’s impact on physiological alterations and oxidative stress in diabetic rats. Biomed Pharmacol J. 2024; 17.
  8. Omonturdiev SZ, Abdullaev AA, Inomjonov DR, Abdullaev IZ, Gayibov UG, Aripov TF. Study of the biological activity of extract Morus nigra. World J Pharm Sci Res. 2024; 3: 164-174.
  9. Hossain MA, AL-Raqmi KAS, AL-Mijizy ZH, Weli AM, Al-Riyami Q. Study of total phenol, flavonoids contents and phytochemical screening of various leaves crude extracts of locally grown Thymus vulgaris. Asian Pac J Trop Biomed. 2013; 3: 705-710.
  10. Gul R, Jan SU, Faridullah S, Sherani S, Jahan N. Preliminary phytochemical screening, quantitative analysis of alkaloids, and antioxidant activity of crude plant extracts from Ephedra intermedia indigenous to Balochistan. Sci World J. 2017; 5873648.
  11. Apostica AG, Ichim T, Radu VM, Bulgariu L. Simple and rapid spectrophotometric method for phenol determination in aqueous media. Bull Polytech Inst Jassy, Constr Archit Sect. 2018; 64: 9-18.
  12. Das BK, Al-Amin MM, Russel SM, Kabir S, Bhattacherjee R, Hannan JM. Phytochemical screening and evaluation of analgesic activity of Oroxylum indicum. Indian J Pharm Sci. 2014; 76: 571-575.
  13. Yadav R, Khare RK, Singhal A. Qualitative phytochemical screening of some selected medicinal plants of Shivpuri District (M.P.). Int J Life Sci Sci Res. 2017; 3.
  14. Litchfield JT Jr, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949; 96: 99-113.
  15. Omolaoye TS, Skosana BT, du Plessis SS. Diabetes mellitus-induction: Effect of different streptozotocin doses on male reproductive parameters. Acta Histochem. 2018; 120: 103-109.
  16. Heath RL, Packer L. Photoperoxidation in isolated chloroplasts. I. Kinetics and stoichiometry of fatty acid peroxidation. Arch Biochem Biophys. 1968; 125: 189-198.
  17. Plamen IZ, Kokova VYu, Apostolova EG, Peychev LP. Possible role of 18-kDa translocator protein (TSPO) in etifoxine-induced reduction of direct twitch responses in isolated rat nerve-skeletal muscle preparations. Trop J Pharm Res. 2018; 17: 1309-1315.
  18. Sudakov NP, Popkova TP, Katyshev AI, et al. Acute myocardial ischemia: patterns of changes in the level of freely circulating mitochondrial DNA in blood during ligation of the upper third of the left descending branch of the coronary artery. Acta Biomed Sci (in Russian). 2013; 5: 150-153.
  19. Hadwan MH. New method for assessment of serum catalase activity. Indian J Sci Technol. 2016; 9.
  20. Nebot C, Moutet M, Huet P, Xu JZ, Yadan JC, Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem. 1993; 214: 442-451.
  21. Hogeboom GH, Schneider WC, Pallade GE. Cytochemical studies of mammalian tissues; isolation of intact mitochondria from rat liver; some biochemical properties of mitochondria and submicroscopic particulate material. J Biol Chem. 1948; 172: 619-635.
  22. Qamar M, et al. Alloxan-induced diabetes: mechanisms and implications. Exp Diabetes Res. 2020; 12: 88-101.
  23. Dalle C, et al. The role of oxidative stress in diabetes-related metabolic disorders. Diabetes Res. 2021; 15: 210-225.
  24. Valente MJ, et al. Cytotoxic effects of Morus nigra extract in high doses. Toxicol Rep. 2016; 23: 678-689.
  25. Zhang L, et al. Alkaloids and tannins in cellular redox balance. Chem Biol. 2021; 45: 302-317.
  26. de Souza LM, et al. Polyphenols in metabolic stress: benefits and potential risks. Nutr Metab. 2020; 17: 98-112.
  27. Imran M, et al. Phytochemical analysis and antioxidant properties of Morus nigra. Phytochemistry. 2021; 34: 789-803.
  28. Katsube T, et al. Antioxidant properties of Morus nigra Journal of Nutritional Science. 2006; 29: 245-257.
  29. Noeman SA, Hamooda HE, Baalash AA. Biochemical study of oxidative stress markers in the liver, kidney, and heart of high-fat diet-induced obesity in rats. Diabetol Metab Syndr. 2011; 3: 17.
  30. Aladyeva T, Zimatkin S. Role of catalase in oxidative stress-related diseases. Journal of Biochemistry. 2018; 52: 345-359.
  31. Ren X, et al. Oxidative stress and endothelial dysfunction in metabolic disorders. Vascular Pharmacology. 2021; 36: 453-467.
  32. Golubovic R, Slezak J. Creatine kinase as a marker of oxidative damage. Cardiovascular Biochemistry. 2019; 14: 102-115.
  33. Li Q, Miao X. Mitochondrial dysfunction and oxidative stress. Cellular Biochemistry. 2020; 19: 567-583.